GlassScriptPhysician profile
Gregory A Robertson
NPI 1932281011
$22,980.83
in general payments reported to CMS, 2019-2025
53 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,504 · 2020: $3,594 · 2021: $2,576 · 2022: $3,073 · 2023: $2,615 · 2024: $3,072 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,232.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,897.36 | 2019-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $2,783.85 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $2,458.73 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $2,253.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pharming Healthcare, INC. | $1,690.73 | 2019-2025 | Ruconest |
| Abbvie INC. | $1,307.49 | 2019-2025 | Ubrelvy, Qulipta, Synthroid |
| Amarin Pharma, INC. | $1,104.81 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $1,030.48 | 2019-2022 | |
| Pfizer INC. | $884.41 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $852.32 | 2022-2024 | Fanapt, Hetlioz |
| Allergan, INC. | $744.24 | 2019-2020 | |
| Astellas Pharma US INC | $577.66 | 2019-2023 | Veozah, Myrbetriq |
| Radius Health, INC. | $508.21 | 2020-2025 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $336.30 | 2019-2025 | Xifaxan, Trulance |
| Corcept Therapeutics | $226.71 | 2024-2025 | Korlym |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.